Infectious Disease Control

Jemincare group has completed the Phase I clinical trial of its anti-SARS-CoV-2 neutralizing antibody JMB2002

SHANGHAI, Sept. 14, 2021 /PRNewswire/ -- Recently, Jemincare group has declared that it has completed phase I clinical trial of self-developed novel coronavirus specific neutralizing antibody (Project code: JMB2002). The clinical trial of JMB2002 was stated in January 2021. A single-center, rand...

2021-09-14 11:43 3214

Gates Foundation's Annual Goalkeepers Report Finds Stark Disparities in COVID-19 Impacts

New data reveals world stepped up to prevent worst-case scenarios from happening; spotlights need for long-term investments to ensure an equitable recovery and continued progress toward the Global Goals SEATTLE, Sept. 14, 2021 /PRNewswire/ -- The Bill & Melinda Gates Foundation today launched it...

2021-09-14 11:00 2632

RedHill Biopharma Accelerates Ongoing U.S. Phase 2/3 COVID-19 Study of Once-Daily Oral RHB-107 in Non-Hospitalized Patients with South African Approval

The South African Health Products Regulatory Authority (SAHPRA) has approved the Phase 2/3 study of once-daily orally-administered RHB-107 (upamostat) for patients with symptomatic COVID-19 who do not require hospital care Number of U.S. sites for the study has also been expanded RHB-107, a nov...

2021-09-13 19:00 5803

Winners of HK$1 million in prizes including a Tesla Model 3 in the Goodman #goodshot Vaccination Lucky Draw announced

Goodman attracted over one million entries to its HK$1 million #goodshot Vaccination Lucky Draw, helping drive a recent surge in the COVID-19 vaccination rate inHong Kong. HONG KONG, Sept. 10, 2021 /PRNewswire/ -- Thirty winners were today announced by Goodman on the#goodshot Lucky Draw website ...

2021-09-10 20:06 4398

3DMed Diagnostics Donates Medical Supplies to Support COVID-19 Fight in Cambodia

SHANGHAI, Sept. 10, 2021 /PRNewswire/ -- Shanghai-based biotechnology company, 3DMed Diagnostics, has donated anti-coronavirus medical appliances worth US$218,000 to Cambodia's Ministry of Health to support its campaign against COVID-19. A handover ceremony was held onFriday September 3 via video ...

2021-09-10 18:22 2880

Whiz Gambit now available across EMEA

HONG KONG, Sept. 10, 2021 /PRNewswire/ -- As the world navigating the new normal, effective cleaning and disinfection practices have never been more important. In response to the growing demand, Whiz Gambit, the 2-in-1 AI-powered cleaning and disinfection robotic solution, jointly launched by So...

2021-09-10 11:00 2670

DiaCarta Receives CE/IVD for its New COVID 19 Screening Test that Identifies Delta Plus and New Variants

PLEASANTON, Calif., Sept. 10, 2021 /PRNewswire/ -- DiaCarta Inc., a precision molecular diagnostics company and leading developer of novel oncology tests using liquid biopsy today announced that its new QuantiVirus™ SARS-CoV-2 Variant Detection Test received the CE/IVD marking and therefore, can ...

2021-09-10 02:02 2367

Biokangtai: Recombinant COVID-19 Vaccine(Adenovirus Vector) licensed for manufacturing, which actively promotes vaccine export and improves vaccine accessibility

SHENZHEN, China, Sept. 8, 2021 /PRNewswire/ -- The other day Shenzhen Kangtai Biological Products Co., Ltd. announced that the company and AstraZeneca signed the "Amendment 1 to License Agreement". In addition to authorizing BIOKANGTAI to commercialize its Recombinant COVID-19 Vaccine(Adenovirus ...

2021-09-09 11:40 3497

Novavax Initiates Phase 1/2 Clinical Trial of Combination Vaccine for COVID-19 and Seasonal Influenza

-- First participants enrolled in Phase 1 clinical trial of combination NanoFlu™/NVX–CoV2373 vaccine with Matrix-M™ adjuvant -- Phase 1/2 study will evaluate immunogenicity and safety GAITHERSBURG, Md., Sept. 8, 2021 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated...

2021-09-08 20:30 5178

Bactiguard appoints new CEO

The Board of Bactiguard Holding AB (publ) has today appointed Anders Göransson as the new CEO. Anders has extensive experience from consulting within McKinsey and has held several senior positions in Amgen, most recently as Head of Innovation Europe. Anders will start his employment in Bactiguard...

2021-09-08 09:51 2408

Further Study in humans shows that the DTH response, the basis for CoviDTH, is highly durable and persists for at least one year after COVID-19 exposure or vaccine administration

VANCOUVER, BC and SAN CRISTÓBAL DE LA LAGUNA, Spain, Sept. 7, 2021 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or "the Company") is pleased to announce that the Scientific Advisor for its CoviDTH program,Yvelise Barrios, MD, PhD, and Clinical Immuno...

2021-09-07 20:00 6024

Brii Biosciences Adds US$100 Million to Advance its Late-Stage Monoclonal Antibody Combination Therapy, BRII-196/BRII-198, for Non-Hospitalized COVID-19 Patients

DURHAM, N.C. and BEIJING, Sept. 7, 2021 /PRNewswire/ -- Brii Biosciences Limited ("Brii Bio" or the "Company", stock code: 2137.HK) a multi-national company developing innovative therapies for diseases with significant unmet medical needs and large public healt...

2021-09-07 19:04 4314

Abu Dhabi Welcomes All Vaccinated Travellers from Around the World, Lifting Quarantine Measures starting 5 September 2021

Unvaccinated travellers from 'Green List' countries also able to enter Abu Dhabi with no quarantine New simple process to verify international vaccination certificates launched to support 'Green Pass' entry guidelines ABU DHABI, UAE, Sept. 3, 2021 /PRNewswire/ -- Following the updated internati...

2021-09-03 22:06 5145

BGI safeguards Ethiopia-China Route with airport COVID-19 testing lab

SHENZHEN, China, Sept. 3, 2021 /PRNewswire/ -- From April to August, 2021, BGI's COVID-19 testing lab has helped 5,500 Chinese travelers safely fly out of  the Addis Ababa Bole International Airport. In April, BGI set up the "Huo-Yan" laboratory, a COVID-19 testing lab, at the airport for pass...

2021-09-03 21:16 3277

PolyU's research finds contact tracing is an effective way for controlling the spread of COVID-19 when borders reopen

HONG KONG, Sept. 1, 2021 /PRNewswire/ -- As some countries in the world begin to consider adjusting their pandemic control strategy from "zero COVID" to "living with COVID", a research study by the Department of Land Surveying and Geo-Informatics at The Hong Kong Polytechnic University (PolyU) ha...

2021-09-01 21:12 2341

Phase 1 of the Vaccination Lucky Draw Sponsored by Ng Teng Fong Charitable Foundation and Chinese Estates Closes with Over 2.5 Million Registrations

HONG KONG, Sept. 1, 2021 /PRNewswire/ -- The Phase 1 Lucky Draw, jointly sponsored by Ng Teng Fong Charitable Foundation Limited ('NTFCF'), the philanthropic arm of Sino Group and Chinese Estates Holdings Limited ('Chinese Estates'), has officially closed for registration. As at the closing time ...

2021-09-01 20:27 2787

6 Interesting Places in the Philippines Worth Seeing After Pandemic

MANILA, Philippines, Aug. 31, 2021 /PRNewswire/ -- In preparation to ensure safe travels for future visitors of the country, under the direction of the Philippine Secretary of Tourism,Berna Romulo-Puyat, the Department of Tourism (DOT) has actively implemented new public health and safety guideli...

2021-08-31 19:33 343

Organ transplants fell by a third worldwide during first wave of COVID-19 pandemic, new study presented at ESOT Congress 2021 shows

MILAN, Aug. 31, 2021 /PRNewswire/ -- The number of solid organ transplants performed during the first wave of COVID-19 in 2020 plunged by 31% compared to the previous year, according to a new global study presented at theEuropean Society for Organ Transplantation (ESOT) Congress 2021

2021-08-31 07:01 1962

Kenya Grants Emergency Use Authorization for the INDICAID(TM) COVID-19 Rapid Antigen Test

HONG KONG, Aug. 30, 2021 /PRNewswire/ -- PHASE Scientific announces that its  INDICAID™ COVID-19 Rapid Antigen Test (INDICAID™) has received Emergency Use Authorization from the Ministry of Health (MOH) of the Republic ofKenya on 17 August 2021. The authorization enables the test to be used in Ken...

2021-08-30 09:00 3881

INOVIO Receives Authorization to Conduct Phase 3 Efficacy Trial of its COVID-19 DNA Vaccine Candidate, INO-4800

INOVIO's global Phase 3 efficacy trial receives authorization to proceed from Brazil; other countries to follow INOVIO to conduct INNOVATE Phase 3 efficacy trial with partner Advaccine in areas of world in need of COVID-19 vaccines PLYMOUTH MEETING, Pa., Aug. 26, 2021 /PRNewswire/ -- INOVIO (NAS...

2021-08-26 20:00 2947
1 ... 24252627282930 ... 78

Week's Top Stories